Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 06, 2023

SELL
$62.39 - $113.8 $4,991 - $9,104
-80 Reduced 37.56%
133 $15,000
Q3 2022

Oct 07, 2022

BUY
$58.92 - $84.67 $5,833 - $8,382
99 Added 86.84%
213 $13,000
Q2 2022

Jul 07, 2022

SELL
$79.4 - $116.36 $1,111 - $1,629
-14 Reduced 10.94%
114 $9,000
Q1 2022

Apr 08, 2022

BUY
$86.42 - $109.81 $345 - $439
4 Added 3.23%
128 $13,000
Q4 2021

Feb 09, 2022

BUY
$98.56 - $119.91 $12,221 - $14,868
124 New
124 $13,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.